Total planned funding: $6,648,113
Allocations
Countries/Regions
Central Asia Region | $6,648,113 |
Organizational Types
Own Agency | $6,648,113 |
Program Areas
Management and Operations | $4,266,162 |
Governance and Systems | $789,236 |
Prevention | $504,037 |
Care | $490,220 |
Treatment | $322,329 |
Testing | $276,129 |
Budget Codes
HVMS: Management and Operations | $4,266,162 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $504,037 |
HBHC: Care: Adult Care and Support | $387,898 |
HLAB: Laboratory Infrastructure | $331,688 |
HTXS: Treatment: Adult Treatment | $304,160 |
HVSI: Strategic Information | $285,258 |
HVCT: Testing: HIV Testing and Counseling | $276,129 |
OHSS: Health Systems Strengthening | $172,290 |
HVTB: Care: TB/HIV | $102,322 |
HTXD: Treatment: ARV Drugs | $18,169 |
Top Partner Programs
USG Aggregated Agencies:
$6,648,113
Countries/Regions
Central Asia Region
2012 | $1,121,824 |
2016 | $4,126,289 |
2017 | $1,400,000 |